OTC · ECIA
Healthcare · Medical - Instruments & Supplies
$0.03
Up+$0.02 (+160.87%)
Updated Nov 5, 2026, 1:03 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ECIA
1M range · 0 trading sessions · Daily adjusted prices
ECIA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning ECIA.
Company
Market Activity
Research & News
ECIA research
Company profile and research snapshot.
ENCISION INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 11, 2026
BOULDER, CO / ACCESS Newswire / September 11, 2026 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced that on September 8, 2026 it completed an $80,000 private placement of common stock with a group of private investors.
Finnhub · May 4, 2026
BOULDER, CO / ACCESS Newswire / May 4, 2026 / Encision Inc. , a medical device company that owns patented Active Electrode Monitoring technology designed to prevent dangerous stray energy burns in...
Finnhub · Apr 13, 2026
BOULDER, CO / ACCESS Newswire / April 13, 2026 / Encision Inc. , a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in...
accessnewswire.com · Nov 14, 2025
BOULDER, CO / ACCESS Newswire / November 14, 2025 / Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2026 second quarter that ended September 30, 2025. The Company posted quarterly product net revenue of $1.48 million and service net revenue of $46 thousand, or total net revenue of $1.52 million, resulting in a quarterly net loss of $268 thousand, or $(0.02) per diluted share.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ECIA.
No results
No recent SID articles mention ECIA.
